MarkAnthonyLevstikMD

PubMed

• 1 citations
  What is the optimal prophylaxis against postoperative deep vein thrombosis in the living donor to avoid complications and enhance recovery? - A systematic review of th...
  Luis I Ruffolo, Mark Levstik, Jen Boehly, Michael Spiro, Dimitri A Raptis, Linda Liu, Roberto Hernandez-Alejandro> ;Clinical Transplantation. 2022 Oct 1
• 2 citations
  Estimating the effect of increasing utilization of living donor liver transplantation using observational data.
  Kerollos Nashat Wanis, Aaron L. Sarvet, Luis I. Ruffolo, Mark Levstik, Koji Tomiyama, Bandar Al-Judaibi, Mats Julius Stensrud, Roberto Hernandez-Alejandro> ;Transplant International. 2021 Feb 1
• 1 citations
  Hepatocellular adenoma(s) arising in nodular regenerative hyperplasia in a patient with systemic lupus erythematosus
  Swan Thung, Stan L. Weiss, Mark Levstik, Dongwei Zhang, Xiaoyan Liao, > ;Pathology, Research and Practice. 2020 Feb 1
• Watching the Clock in Donation After Circulatory Death Liver Transplantation.
  Luis I. Ruffolo, Mark Levstik, Roberto Hernandez-Alejandro> ;Liver Transplantation. 2019 Sep 1
• 11 citations
  Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience
  Mauro E. Tun-Abraham, Kerollos Nashat Wanis, Carlos Garcia-Ochoa, Nathalie Sela, Hemant Sharma, Ibrahim Al Hasan, Douglas Quan, Bandar Al-Judaibi, Mark Levstik, Robert...> ;Canadian Journal of Surgery. Journal Canadien De Chirurgie. 2019 Feb 1
• 6 citations
  The meaning of confounding adjustment in the presence of multiple versions of treatment: an application to organ transplantation.
  Kerollos Nashat Wanis, Arin L. Madenci, Mary Katherine Dokus, Mark S. Orloff, Mark Levstik, Roberto Hernandez-Alejandro, Miguel A. Hernán> ;European Journal of Epidemiology. 2019 Jan 23
• 4 citations
  Optimizing associated liver partition and portal vein ligation for staged hepatectomy outcomes: Surgical experience or appropriate patient selection?
  Ibrahim Al Hasan, Mauro E. Tun-Abraham, Kerollos Nashat Wanis, Carlos Garcia-Ochoa, Mark Levstik, Bandar Al-Judaibi, Roberto Hernandez-Alejandro> ;Canadian Journal of Surgery. Journal Canadien De Chirurgie. 2017 Dec 1
• 47 citations
  The influence of functional warm ischemia time on DCD Liver Transplant Recipients’ Outcomes
  Jessica C. Coffey, Kerollos Nashat Wanis, Diethard Monbaliu, Nicholas Gilbo, Markus Selzner, Neeta Vachharajani, Mark Levstik, Max Marquez, M.B. Majella Doyle, Jacques...> ;Clinical Transplantation. 2017 Oct 1
• 7 citations
  Tobacco Use is a Modifiable Risk Factor for Post-Transplant Biliary Complications.
  David T. Dulaney, Katherine M. Dokus, Scott McIntosh, Bandar Al-Judaibi, Gopal A. Ramaraju, Koji Tomiyama, Mark Levstik, Roberto Hernandez-Alejandro, Mark S. Orloff, R...> ;Journal of Gastrointestinal Surgery. 2017 Aug 7
• 36 citations
  Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multicenter IDOL Consortium.
  David S. Goldberg, Seth J. Karp, Maureen McCauley, James F. Markmann, Kristopher P. Croome, C. Burcin Taner, Julie K. Heimbach, Michael D. Leise, Jonathan P. Fryer, Hu...> ;Transplantation. 2017 May 1
• 1 citations
  Hepatectomy for Early Hepatocellular Carcinoma: Not If, but When and How?
  Roberto Hernandez-Alejandro, Mark Levstik, David C. Linehan> ;JAMA Surgery. 2017 Mar 1
• 8 citations
  Reuse of liver grafts following the brain death of the initial recipient.
  Hideaki Tanaka, Vivian C. McAlister, Mark Levstik, Cameron N. Ghent, Paul Marotta, Douglas Quan, William Wall> ;World Journal of Hepatology. 2014 Jun 27
• 3 citations
  Increased duration of dual pegylated interferon and ribavirin therapy for genotype 1 hepatitis C post-liver transplantation increases sustained virologic response: a r...
  Malcolm Wells, Lee S Roth, Paul Marotta, Mark Levstik, Andrew Mason, Vincent G. Bain, Natasha Chandok, Bandar Al-Judaibi> ;Saudi Journal of Gastroenterology. 2013 Sep 1
• 61 citations
  Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease.
  Melanie D. Beaton, Subrata Chakrabarti, Mark Levstik, Mark Speechley, Paul Marotta, Paul C. Adams> ;Alimentary Pharmacology & Therapeutics. 2013 Apr 1
• 79 citations
  Representing complexity well: a story about teamwork, with implications for how we teach collaboration
  Lorelei Lingard, Allan McDougall, Mark Levstik, Natasha Chandok, Marlee M. Spafford, Catherine F. Schryer> ;Medical Education. 2012 Sep 1
• 39 citations
  The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.
  Amindeep Sandhu, Turki AlAmeel, Cheryl Dale, Mark Levstik, Nilesh Chande> ;Alimentary Pharmacology & Therapeutics. 2012 Jul 1
• 240 citations
  Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
  Robert P. Myers, Aaron Pollett, Richard Kirsch, Gilles Pomier-Layrargues, Melanie D. Beaton, Mark Levstik, Andres Duarte-Rojo, David Wong, Pam Crotty, Magdy Elkashab> ;Liver International. 2012 Jul 1
• 130 citations
  Meta‐analysis: vasoactive medications for the management of acute variceal bleeds
  Malcolm Wells, Nilesh Chande, Paul C. Adams, Melanie D. Beaton, Mark Levstik, E. Boyce, Marko Mrkobrada> ;Alimentary Pharmacology & Therapeutics. 2012 Jun 1
• 32 citations
  Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
  Kris P. Croome, Paul Marotta, William Wall, Cheryl Dale, Mark Levstik, Natasha Chandok, Roberto Hernandez-Alejandro> ;Transplantation Proceedings. 2012 Jun 1
• 110 citations
  Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe
  Robert P. Myers, Gilles Pomier-Layrargues, Richard Kirsch, Aaron Pollett, Melanie D. Beaton, Mark Levstik, Andres Duarte-Rojo, David Wong, Pam Crotty, Magdy Elkashab> ;Journal of Hepatology. 2012 Mar 1
• 385 citations
  Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
  Robert P. Myers, Gilles Pomier-Layrargues, Richard Kirsch, Aaron Pollett, Andres Duarte-Rojo, David Wong, Melanie D. Beaton, Mark Levstik, Pam Crotty, Magdy Elkashab> ;Hepatology. 2012 Jan 1
• 6 citations
  The role of hepatitis B immunoglobulin in hepatitis B related liver transplantation: Canadian Transplant Centre Position Paper.
  Mark Levstik, Philip Wong, Erica D. Greanya, Eric M. Yoshida> ;Annals of Hepatology. 2011 Oct 1
• 29 citations
  Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts.
  Roberto Hernandez-Alejandro, Kris P. Croome, Douglas Quan, Mohamed Mawardi, Natasha Chandok, Cheryl Dale, Vivian C. McAlister, Mark Levstik, William Wall, Paul Marotta> ;Transplantation. 2011 Sep 27
• 7 citations
  The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients
  Mohammad Mawardi, Faisal Aba Alkhail, Kazuhiro Katada, Mark Levstik, Douglas Quan, William Wall, Paul Marotta, Roberto Hernandez-Alejandro> ;Hepatology International. 2011 Jan 15
• 14 citations
  Ranking in Canadian gastroenterology residency match: what do residents and program directors want?
  Khurram J. Khan, Mark Levstik> ;Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 2010 Jun 1
• Join now to see all